ArticleActa pharmaceutica Sinica. B2021

PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma.

Min Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.